Metraipolis › archive › dc_2ff49fcf8ac2

Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report — Europe PMC PMID:42343990

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42343990
DOI
10.3892/mco.2026.2961
License (as archived)
solo-consultazione
Archived
2026-10-31T16:42:24.481Z
SHA-256 of the archived text
a776623904f9208a7d87daf491bc6c50f5dfde963f6fce7bbbdbbe84329497db
Stable URL of this page
https://metraipolis.com/documento/dc_2ff49fcf8ac2

How to cite

Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report — Europe PMC PMID:42343990 — Europe PMC (en), https://europepmc.org/article/MED/42343990 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ff49fcf8ac2 (Metraipolis archive dc_2ff49fcf8ac2, sha256 a776623904f9208a7d87daf491bc6c50f5dfde963f6fce7bbbdbbe84329497db)
BibTeX
@misc{dc2ff49fcf8ac2,
  title = {Occult breast cancer showing a marked response to pembrolizumab plus gemcitabine and carboplatin therapy complicated by immune-related colitis: A case report — Europe PMC PMID:42343990},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42343990},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ff49fcf8ac2; sha256 a776623904f9208a7d87daf491bc6c50f5dfde963f6fce7bbbdbbe84329497db},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42343990. Agents can read the archived copy with the MCP tool read_document.